| Standard name | Systematic name | Name description | Description |
|---|---|---|---|
| CLD1 | YGR110W | Mitochondrial cardiolipin-specific phospholipase | Mitochondrial cardiolipin-specific phospholipase; functions upstream of Taz1p to generate monolyso-cardiolipin; transcription increases upon genotoxic stress; involved in restricting Ty1 transposition; has homology to mammalian CGI-58 |
Cell cycle phase and timing of transcription peak
| Cell cycle phase | Time (min) |
|---|---|
CYCLoPs localization & abundance
| WT1 | WT2 | WT3 |
|---|---|---|
| no data | no data | no data |
GFP localization & abundance
| GFP localization | GFP abundance |
|---|---|
| no data | no data |
GO term count
| Metabolism | Cell cycle | Cell division | Signal transduction | DNA replication | |
|---|---|---|---|---|---|
| CLD1 | 4 | 0 | 0 | 0 | 0 |
Enzyme information
| Catalyzed reactions in Yeast8 |
|---|
| r_2595 (CL (1-18:0, 2-16:1, 3-16:1, 4-18:1) phospholipase (1-position), mitochondrial membrane), r_2584 (CL (1-16:0, 2-16:1, 3-16:0, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2590 (CL (1-18:0, 2-16:1, 3-16:0, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2596 (CL (1-16:0, 2-18:1, 3-16:0, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2602 (CL (1-16:0, 2-16:1, 3-16:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2608 (CL (1-18:0, 2-16:1, 3-16:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2614 (CL (1-16:0, 2-18:1, 3-16:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2613 (CL (1-18:1, 2-16:1, 3-16:0, 4-18:1) phospholipase (3-position), mitochondrial membrane), r_2585 (CL (1-16:0, 2-16:1, 3-16:1, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2591 (CL (1-18:0, 2-16:1, 3-16:1, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2597 (CL (1-16:0, 2-18:1, 3-16:1, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2603 (CL (1-16:0, 2-16:1, 3-18:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2609 (CL (1-18:0, 2-16:1, 3-18:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2615 (CL (1-16:0, 2-18:1, 3-18:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2601 (CL (1-16:0, 2-18:1, 3-16:1, 4-18:1) phospholipase (1-position), mitochondrial membrane), r_2592 (CL (1-18:0, 2-16:1, 3-18:0, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2616 (CL (1-16:0, 2-18:1, 3-16:0, 4-18:1) phospholipase (3-position), mitochondrial membrane), r_2586 (CL (1-16:0, 2-16:1, 3-18:0, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2610 (CL (1-18:0, 2-16:1, 3-16:0, 4-18:1) phospholipase (3-position), mitochondrial membrane), r_2604 (CL (1-16:0, 2-16:1, 3-16:0, 4-18:1) phospholipase (3-position), mitochondrial membrane), r_2598 (CL (1-16:0, 2-18:1, 3-18:0, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2587 (CL (1-16:0, 2-16:1, 3-18:1, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2593 (CL (1-18:0, 2-16:1, 3-18:1, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2599 (CL (1-16:0, 2-18:1, 3-18:1, 4-16:1) phospholipase (1-position), mitochondrial membrane), r_2605 (CL (1-16:1, 2-16:1, 3-16:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2611 (CL (1-18:1, 2-16:1, 3-16:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2617 (CL (1-16:1, 2-18:1, 3-16:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2589 (CL (1-16:0, 2-16:1, 3-16:1, 4-18:1) phospholipase (1-position), mitochondrial membrane), r_2607 (CL (1-16:1, 2-16:1, 3-16:0, 4-18:1) phospholipase (3-position), mitochondrial membrane), r_2618 (CL (1-16:1, 2-18:1, 3-18:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2588 (CL (1-16:0, 2-16:1, 3-16:0, 4-18:1) phospholipase (1-position), mitochondrial membrane), r_2594 (CL (1-18:0, 2-16:1, 3-16:0, 4-18:1) phospholipase (1-position), mitochondrial membrane), r_2600 (CL (1-16:0, 2-18:1, 3-16:0, 4-18:1) phospholipase (1-position), mitochondrial membrane), r_2606 (CL (1-16:1, 2-16:1, 3-18:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2612 (CL (1-18:1, 2-16:1, 3-18:0, 4-16:1) phospholipase (3-position), mitochondrial membrane), r_2619 (CL (1-16:1, 2-18:1, 3-16:0, 4-18:1) phospholipase (3-position), mitochondrial membrane) |
List of interactors
Use the search utility to find the interactor you are looking for. By clicking the column headers the table will be sorted on that column. Use shift+click to sort on multiple columns. Default sorting is on number of experiments, number of unique methods and the number of publications, and alphabetical on standard name, in that order.| Standard name | Systematic name | Name description | Type | #Experiments | #Methods | #Publications | Evidence |
|---|---|---|---|---|---|---|---|
| TAZ1 | YPR140W | Lyso-phosphatidylcholine acyltransferase | genetic | 5 | 3 | 4 | Synthetic Growth Defect, Phenotypic Suppression, Synthetic Rescue, Phenotypic Suppression, Phenotypic Suppression |
| DEP1 | YAL013W | Component of the Rpd3L histone deacetylase complex | genetic | 2 | 1 | 2 | Negative Genetic, Negative Genetic |
| TMA17 | YDL110C | Regulatory gamma subunit of fatty acid synthase (FAS) | genetic | 2 | 1 | 2 | Negative Genetic, Negative Genetic |
| SOV1 | YMR066W | Mitochondrial protein of unknown function | genetic | 2 | 1 | 1 | Synthetic Growth Defect, Synthetic Growth Defect |
| RGR1 | YLR071C | Subunit of the RNA polymerase II mediator complex | regulation | 1 | 1 | 1 | chromatin immunoprecipitation-chip evidence |
| YAP6 | YDR259C | Basic leucine zipper (bZIP) transcription factor | regulation | 1 | 1 | 1 | chromatin immunoprecipitation-chip evidence |
| SUA7 | YPR086W | Transcription factor TFIIB | regulation | 1 | 1 | 1 | chromatin immunoprecipitation-chip evidence |
| GCN4 | YEL009C | bZIP transcriptional activator of amino acid biosynthetic genes | regulation | 1 | 1 | 1 | DNA to cDNA expression microarray evidence |
| RPD3 | YNL330C | Histone deacetylase, component of both the Rpd3S and Rpd3L complexes | regulation | 1 | 1 | 1 | chromatin immunoprecipitation-chip evidence |
| HAP1 | YLR256W | Zinc finger transcription factor | regulation | 1 | 1 | 1 | chromatin immunoprecipitation-chip evidence |
| ACT1 | YFL039C | Actin, structural protein in cytoskeleton | genetic | 1 | 1 | 1 | Negative Genetic |
| CDC25 | YLR310C | Membrane bound guanine nucleotide exchange factor | genetic | 1 | 1 | 1 | Positive Genetic |
| BZZ1 | YHR114W | SH3 domain protein implicated in regulating actin polymerization | physical | 1 | 1 | 1 | Two-hybrid |
| CAT5 | YOR125C | Protein required for ubiquinone (Coenzyme Q) biosynthesis | genetic | 1 | 1 | 1 | Dosage Rescue |
| NAB2 | YGL122C | Nuclear polyadenylated RNA-binding protein | physical | 1 | 1 | 1 | Affinity Capture-RNA |
| SSC1 | YJR045C | Hsp70 family ATPase | physical | 1 | 1 | 1 | Affinity Capture-MS |
| SNT1 | YCR033W | Set3C histone deacetylase scaffold | genetic | 1 | 1 | 1 | Positive Genetic |
| UPS1 | YLR193C | Phosphatidic acid transfer protein | genetic | 1 | 1 | 1 | Negative Genetic |
| NPL3 | YDR432W | RNA-binding protein | genetic | 1 | 1 | 1 | Synthetic Growth Defect |
| ESS1 | YJR017C | Peptidylprolyl-cis/trans-isomerase (PPIase) | genetic | 1 | 1 | 1 | Synthetic Rescue |
| TSC11 | YER093C | Subunit of TORC2 (Tor2p-Lst8p-Avo1-Avo2-Tsc11p-Bit61p) | genetic | 1 | 1 | 1 | Positive Genetic |
| CMD1 | YBR109C | Calmodulin | genetic | 1 | 1 | 1 | Negative Genetic |
| TIM22 | YDL217C | Essential core component of mitochondrial TIM22 complex | genetic | 1 | 1 | 1 | Negative Genetic |
| PET117 | YER058W | Assembly factor that couples heme a synthesis to complex IV assembly | genetic | 1 | 1 | 1 | Negative Genetic |
| GCN20 | YFR009W | Positive regulator of the Gcn2p kinase activity | genetic | 1 | 1 | 1 | Negative Genetic |
| YGL114W | YGL114W | Putative protein of unknown function | genetic | 1 | 1 | 1 | Negative Genetic |
| YGL235W | YGL235W | Putative protein of unknown function | genetic | 1 | 1 | 1 | Negative Genetic |
| DDL1 | YOR022C | DDHD domain-containing phospholipase A1 | genetic | 1 | 1 | 1 | Phenotypic Enhancement |
| SPO19 | YPL130W | Meiosis-specific prospore protein | genetic | 1 | 1 | 1 | Negative Genetic |